EASL 2017: Besifovir and Tenofovir Exalidex Look Promising for Hepatitis B

Press/Media: Press / Media

Period	2017 May 3

Media coverage

Title	EASL 2017: Besifovir and Tenofovir Exalidex Look Promising for Hepatitis B
Media name/outlet	HIV and Hepatitis.com
Country	United States
Date	17/5/3
URL	www.hivandhepatitis.com/hbv-treatment/experimental-hbv-drugs/6058-easl-2017-besifovir-and-tenofovir-exalidex-look-promising-as-new-hepatitis-b-drugs
Persons	SangHoon Ahn